Atlas Trials

Melanoma of Unknown Primary

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Melanoma of Unknown Primary

RecordFirmDate
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma (NCT04708418)National Cancer Institute (NCI)2021-10-15
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement (NCT04221438)ECOG-ACRIN Cancer Research Group2021-09-22
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial (NCT04462406)ECOG-ACRIN Cancer Research Group2021-02-09
Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma (NCT03033576)National Cancer Institute (NCI)2017-10-23
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases (NCT02858869)Emory University2016-10-04
A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma (NCT02129075)National Cancer Institute (NCI)2014-04-09

Track Melanoma of Unknown Primary automatically

Every clearance here is in the API, with alerts when new ones post.